BioMarin Pharmaceuticals BMRN Deferred Taxes
Deferred Taxes at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's deferred taxes?
- BioMarin Pharmaceuticals (BMRN) reported deferred taxes of $9.22M in Q1 2026.
- How has BioMarin Pharmaceuticals's deferred taxes changed year-over-year?
- BioMarin Pharmaceuticals's deferred taxes decreased by 67.6% year-over-year, from $28.43M to $9.22M.
- What is the long-term trend for BioMarin Pharmaceuticals's deferred taxes?
- Over 3 years (2021 to 2024), BioMarin Pharmaceuticals's deferred taxes has grown at a 53.2% compound annual growth rate (CAGR), from -$15.61M to $56.1M.
- What does deferred taxes mean?
- Taxes that are accrued but will be paid or realized in future periods.
- How do you interpret deferred taxes?
- Changes reflect shifts in the timing of tax obligations and can indicate future cash tax liabilities.
- How does deferred taxes compare across companies?
- Standard for large corporations with complex tax structures.